Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).
Founded in 1989, Medis Medical Imaging Systems B.V. provides high-quality quantitative analysis solutions for cardiovascular imaging to the medical community. Medis’ software is internationally appreciated due to its ease of use and clinical outcomes for patients. The company continuously focuses on creating, researching and innovating towards clinically relevant software solutions in the field of cardiovascular imaging.
Oaklins’ team in the Netherlands acted as the exclusive strategic advisor to the shareholders and management of Medis Medical Imaging Systems B.V.
Maya Barley
CEO, Medis Medical Imaging Systems B.V.
Talk to the deal team
Related deals
NetNordic has acquired Itectra
Norvestor-backed NetNordic has acquired Danish optical network solutions firm Itectra. The transaction marks NetNordic’s 25th acquisition since 2015, further strengthening its position in the Nordic market. It enables NetNordic to expand its market relevance through deeper expertise in optical network solutions, consolidating its standing in larger Nordic projects and creating cross-selling opportunities between NetNordic’s network solutions and Itectra’s optical capabilities.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreMatera has acquired a majority stake in Fáciltech
Matera has acquired a controlling stake in Fáciltech. The acquisition represents a strategic step to expand Matera’s client base and strengthen its core banking offering, incorporating specialized operational management and ERP solutions that serve institutions with different profiles and business models.
Learn more